Security key
004468500
ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV)
CUSIP: 004468500
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 23,239,545
- Total 13F value
- $115,291,318
- Share change
- +7,083,476
- Put/Call ratio
- 24%
- SEC-reported price per share
- $4.97
- Number of holders
- 77
- Value change
- +$36,552,641
- Number of buys
- 43
- Number of sells
- 22
- Shares outstanding
- 106,975,205
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
77
Top holders
10
ACHV full security history
Ownership snapshot
Full 13F holder table
ACHIEVE LIFE SCIENCES, INC. SEC filings
ACHIEVE LIFE SCIENCES, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of ACHV - ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TPG GP A, LLC
Disclosed value leader
TPG GP A, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 13%
13D/G row: TPG GP A, LLC
Showing 1-6 of 15 holder rows.
Quick read
TPG GP A, LLC leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TPG GP A, LLC's linked filing trail.
Comparable ownership
Top 5
TPG GP A, LLC
13%
Alyeska Investment Group, L.P.
5.6%
VANGUARD GROUP INC
5%
Contrarian Alpha, LP
4.9%
Propel Bio Management, LLC
3.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TPG GP A, LLC |
13D/G
|
13%
|
$40,440,170
13,755,160 shares
|
$0 | 17 Apr 2025 |
| Alyeska Investment Group, L.P. |
13D/G
13F
Company
|
5.6%
|
$9,395,574
2,982,722 shares
|
-$6,098,715 | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group
|
5%
from 13D/G
|
$7,754,676
2,461,802 shares
|
— | 30 Sep 2025 |
| Contrarian Alpha, LP |
13D/G
Parker Quillen
|
4.9%
|
$7,964,388
2,528,377 shares
|
$0 | 30 Sep 2025 |
| Propel Bio Management, LLC |
13F
Company
|
3.5%
|
$11,927,239
3,786,425 shares
|
— | 30 Sep 2025 |
| Simplify Asset Management Inc. |
13F
Company
|
1.1%
|
$3,731,213
1,184,512 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
77
Shares
23,239,545
Rows available
77
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
65
Q4 2025 holders
77
Holder diff
12
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|